Clinical Trial Update: Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial comparing three GVHD prophylaxis regimens in nonmyeloablative or reduced-intensity conditioning unrelated donor transplantation; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Aggressive Non-hodgkin Lymphoma
• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Hodgkin Lymphoma
• Mantle Cell Lymphoma
• Myelodysplastic Syndrome

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED